Germany Next Generation Sequencing Market worth $1,960.3 million by 2031
The report "Germany Next-generation Sequencing Market by Product (Reagents, Kits, Platforms) Service (CHIP Sequencing, Whole Genome, Methyl, RNA Sequencing), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Application - Forecast to 2031" is expected to reach USD 1,960.3 million by 2031 from USD 934.3 million in 2026, at a CAGR of 16.0%.
Browse 60 market data Tables and 18 Figures spread through 250 Pages and in-depth TOC on "Germany Next-generation Sequencing Market by Product (Reagents, Kits, Platforms) Service (CHIP Sequencing, Whole Genome, Methyl, RNA Sequencing), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Application - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/germany-next-generation-sequencing-market-268416242.html
Key factors driving growth in the Germany next-generation sequencing market include ongoing advancements in sequencing technologies that enable faster, more accurate, and cost-effective genomic analysis. Rising demand for precision medicine and the expanding use of NGS in oncology research and clinical diagnostics further support market growth. Germany also functions as a key research hub in Europe, backed by strong government funding from the German Federal Ministry of Education and Research and national initiatives such as the German Alliance for Precision Medicine, which enhance the country’s genomic research capabilities. Additionally, the development of advanced technologies such as long-read sequencing improves the detection of complex genetic variations, which is especially important for studying rare diseases affecting millions in Germany. Furthermore, the incorporation of artificial intelligence and machine learning into genomic data analysis is opening new opportunities to improve sequencing efficiency and promote broader adoption of NGS technologies.
The products segment is expected to hold the largest market share in Germany next-generation sequencing market during the forecast period.
Germany next-generation sequencing market is segmented into products and services. The product segment holds the largest share at 71.5%. This dominance is due to the widespread adoption of sequencing instruments, reagents, and consumables necessary for routine genomic research and clinical applications testing.
The sequencing services segment is projected to account for significant growth in the Germany next-generation sequencing market.
By service type, the Germany next-generation sequencing market is divided into sequencing services, pre-sequencing services, bioinformatics and data analysis services, and services for NGS platforms. Sequencing services are expected to see significant market growth during the forecast period, with a projected CAGR of 20.4%. This growth is mainly driven by the rising demand for outsourced sequencing among research institutes, pharmaceutical companies, and clinical laboratories that seek cost-effective access to advanced sequencing technologies without investing in costly infrastructure and specialized expertise.
Germany is expected to maintain its position as a leading market for the European next-generation sequencing market during the forecast period.
Germany’s emphasis on research collaboration and ongoing funding from organizations like the German Federal Ministry of Education and Research is vital in maintaining the country’s leading position in the European next-generation sequencing (NGS) market. Advances in genomic research and the growth of precision medicine initiatives continue to drive market expansion. Furthermore, Germany’s established healthcare and research infrastructure support the effective use of advanced sequencing platforms and digital diagnostic tools. Strong partnerships among research institutes, healthcare providers, and industry players further accelerate the development and adoption of NGS-based diagnostics. Together, these factors solidify Germany’s ongoing leadership in the European NGS market during the forecast period.
The report profiles key players such as Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Oxford Nanopore Technologies plc (UK), PacBio (US), and Eurofins Scientific (Luxembourg).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Germany Next Generation Sequencing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
